Utility of CAML as Diagnostic for Early Stage Lung Cancer

NCT03992183 · clinicaltrials.gov ↗
TERMINATED
Status
200
Enrollment
OTHER
Sponsor class

Stopped Slow accrual

Conditions

Sponsor

Fox Chase Cancer Center

Collaborators